However, as with any therapeutic agent, further studies are needed to understand the full scope of PQ10’s effects and its safety profile. Long-term studies exploring its impact on various populations will be crucial to determining its place in standard treatment protocols.
Similarly, the compound's potential anticancer properties are intriguing. Cancer cells often exhibit rapid growth and unchecked division, relying on nucleic acids for the synthesis of proteins that support their proliferative nature. By influencing nucleic acid metabolism, 6-chloro-1,3-dimethyluracil may interfere with the growth of malignant cells, similar to how other antimetabolites function. Research indicates that certain derivatives of uracil and its analogues can induce apoptosis in cancer cells, making 6-chloro-1,3-dimethyluracil a candidate for further studies in cancer therapy.